Company:  LIGAND PHARMACEUTICALS IN ... (LGND)
Form Type:  8-K
Filing Date:  8/8/2022 
CIK:  0000886163 
Address:  3911 SORRENTO VALLEY BLVD
SUITE 110
 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-550-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$70.50  
Change: 
-2.40 (-3.29%)  
Trade Time: 
02:39 PM EST  
Market Cap: 
$1.19B
Trade LGND now with 

© 2022  
Description of Business
We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 140 pharmaceutical and biotechnology companies. Over 400 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET